SGMT
Sagimet Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.09
−0.72%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.25
- Revenue estimate
- $166.7K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.25
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +11.8%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $29
- PT range
- $11 – $56
- Analysts
- 5
5 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.25 | -$0.26 | Miss -3.59% | — |
| May 12, 2026 | -$0.39 | -$0.33 | Beat 15.38% | — |
| Mar 11, 2026 | -$0.43 | -$0.29 | Beat 32.90% | — |
| Nov 13, 2025 | -$0.41 | -$0.40 | Beat 2.44% | — |
| Aug 13, 2025 | -$0.52 | -$0.32 | Beat 38.46% | — |
| May 8, 2025 | -$0.79 | -$0.56 | Beat 29.11% | — |
| Mar 12, 2025 | -$0.65 | -$0.50 | Beat 23.08% | — |
| Nov 14, 2024 | -$0.47 | -$0.45 | Beat 4.26% | — |
| Aug 14, 2024 | -$0.34 | -$0.25 | Beat 26.47% | — |
| May 15, 2024 | -$0.41 | -$0.23 | Beat 43.90% | — |
| Nov 13, 2023 | -$1.02 | -$0.35 | Beat 65.69% | $2.0M |
| Jul 14, 2023 | -$0.50 | -$36 | Miss -7060.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026